U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07934511) titled 'Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke' on Nov. 06.
Brief Summary: Stroke is a major cause of disability and the second leading cause of death in adults. Some strokes are linked to atrial fibrillation (AF), a type of irregular heartbeat. When AF is found, doctors usually prescribe blood-thinning medicines to help prevent another stroke. If AF is not found, patients are usually treated with antiplatelet medicines, such as aspirin.
However, AF can be difficult to detect. Because of this, doctors may not know which treatment is best.
Our research team ha...